Letter page one:
Letter page 2:
Letter page 3:
Johnson & Johnson stung by its own Advisory Committee–Natrecor should be strictly limited Fri, 12 Aug 2005 Kudos go to Dr. Eugene Braunwald and the 10 members of the advisory committee that he heads. Contrary to Johnson & Johnson expectations, the committee recommended extensive warnings to physicians against prescribing Natrecor…
Disclosure of the egregious ethical, methodological and legal violations outlined in the letter of determination by the Federal Office of Human Research Protections (OHRP) regarding the so-called SUPPORT oxygen experiment. . . .
Efforts to promote Cymbalta for Fibromyalgia symptoms Wed, 20 Oct 2004 Cymbalta (duloxetine) was approved by the FDA as a treatment for depression in adults. No doubt in an effort to expand the drugs’ market, Eli Lilly tested the drug in patients with fibromyalgia. The published report claims women who…
Gene Therapy Experiment Called “Crazy” Tue, 19 Aug 2003 The New York Times reports about yet another example of the ‘Cowboy’ approach to medical research. Doctors who founded Neurologix, a private company that is paying for New York-Presbyterian Hospital to test the safety of a radical experimental approach to treat…
Corruption in drug research – NYT Corruption in Medicine – BMJ Sat, 23 Nov 2002 Two powerful exposes focus on the corruption of academic medicine on both sides of the Atlantic. Melody Peterson’s front page investigative report in The New York Times (released simultaneously with PBS broadcast with Bill Moyers),…
LA Times: NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling Fri, 22 Apr 2005 Pulitzer Prize winner David Willman of the Los Angeles Times, whose investigative reporting first revealed the major covert conflicts of interest among top scientists and administrators at the National Institutes of Health (NIH), reports…
